SLG
LOGC

Stanley-Laman Group’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History

Stanley-Laman Group’s Portfolio LOGC Stock Details LOGC Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-19,530
Closed -$211K – 299
2019
Q3 		$211K Hold
19,530
– – 0.05% 257
2019
Q2 		$254K Buy
+19,530
New +$254K 0.06% 249